Optimal Control of a Delayed Hepatitis B Viral Infection Model with DNA-Containing Capsids and Cure Rate
From MaRDI portal
Publication:5208466
DOI10.1007/978-3-030-23433-1_2zbMATH Open1430.92107OpenAlexW2977924684MaRDI QIDQ5208466FDOQ5208466
Publication date: 16 January 2020
Published in: Trends in Biomathematics: Mathematical Modeling for Health, Harvesting, and Population Dynamics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/978-3-030-23433-1_2
Medical epidemiology (92C60) Epidemiology (92D30) Applications of optimal control and differential games (49N90)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Differential equations. Classical to controlled
- Mathematical analysis of a basic virus infection model with application to HBV infection
- A differential equation model of HIV infection of CD4\(^+\) \(T\)-cells with cure rate
- Global properties of an improved hepatitis B virus model
- Modeling the mechanisms of acute hepatitis B virus infection
- Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis
- Optimal control of a delayed HIV infection model with immune response using an efficient numerical method
- Global stability of one and two discrete delay models for chronic hepatitis B infection with HBV DNA-containing capsids
- Optimal control of a delayed hepatitis B viral infection model with HBV DNA‐containing capsids and CTL immune response
- Global properties of a HBV infection model with HBV DNA-containing capsids and CTL immune response
- Global stability and a non-standard finite difference scheme for a diffusion driven HBV model with capsids
Cited In (1)
This page was built for publication: Optimal Control of a Delayed Hepatitis B Viral Infection Model with DNA-Containing Capsids and Cure Rate
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5208466)
